← Open Payments lookup

KENNETH MEIER: Open Payments

NPI 1770049264 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$558 in 18 payments from 9 companies in 2025. Trend: 2023 $704 · 2024 $791 · 2025 $558

Food & beverage: $558
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$257
PFIZER INC.4$85
Lilly USA, LLC4$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37
Novo Nordisk Inc1$27
Esperion Therapeutics, Inc.1$21
Exact Sciences Corporation1$17
Acella Pharmaceuticals, LLC1$16
Bayer Healthcare Pharmaceuticals Inc.1$15

Products named: AIRSUPRA, FARXIGA, NURTEC ODT, MOUNJARO, XIFAXAN, Rybelsus, NEXLETOL, ELIQUIS.

Industry payments across NV — which companies pay providers there.